Fidelity Investments’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Fidelity Investments’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-27	Closed	-$1K	–	5224
2021 Q4	$1K	Buy	27 +12	+80%	+$720	﹤0.01%	4144
2021 Q3	$1K	Buy	+15	New	+$1.08K	﹤0.01%	4149
2021 Q2	–	Sell	-33,162	Closed	-$1.61M	–	4559
2021 Q1	$1.61M	Sell	33,162 -19,710	-37%	-$1.07M	﹤0.01%	2506
2020 Q4	$2.49M	Buy	52,872 +347	+0.7%	+$13.7K	﹤0.01%	2353
2020 Q3	$2.47M	Hold	52,525	–	–	﹤0.01%	2258
2020 Q2	$1.57M	Buy	+52,525	New	+$1.09M	﹤0.01%	2321

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments's NBP Position: Q1 2022 in Review

Fidelity Investments sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2022, closing a stake of 27 shares — an estimated $1K sold.

Fidelity Investments first reported a position in NBP in Q2 2020 and held it in 6 quarters. The position peaked at $2.49M in Q4 2020. 120 funds tracked by Wall St. Rank hold NBP as of Q1 2022.

Fidelity Investments reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2022 after selling out during the quarter.
Fidelity Investments sold 27 NovaBridge Biosciences American Depositary Shares shares in Q1 2022, an estimated $1K.
Fidelity Investments first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2020 and held it in 6 quarters.
Fidelity Investments's NovaBridge Biosciences American Depositary Shares position peaked at $2.49M in Q4 2020.
120 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2022.

Based on Fidelity Investments's 13F filing for Q1 2022, filed 13 May 2022.